active: true
branding:
    icon_url: https://api.polygon.io/v1/reference/company-branding/aHV0Y2gtbWVkLmNvbQ/images/2025-04-04_icon.jpeg
    logo_url: https://api.polygon.io/v1/reference/company-branding/aHV0Y2gtbWVkLmNvbQ/images/2025-04-04_logo.png
cik: 0001648257
composite_figi: BBG00B6VCGJ1
currency_name: usd
description: HUTCHMED (China) Ltd is an biopharmaceutical company engaged in the discovery,
    development, and commercialization of targeted therapies and immunotherapies for
    the treatment of cancer and immunological diseases. The company has a portfolio
    of several cancer drug candidates currently in clinical studies around the world
    and extensive commercial infrastructure in its home market of China. The company
    operates in two reportable segments Oncology/Immunology, and Other Ventures.
homepage_url: https://www.hutch-med.com
list_date: '2016-03-17'
locale: us
market: stocks
market_cap: 2749763808.0
name: HUTCHMED (China) Limited American Depositary Shares
primary_exchange: XNAS
round_lot: 100
share_class_figi: BBG00B6VCGK9
share_class_shares_outstanding: 174422294
ticker: HCM
ticker_root: HCM
total_employees: 1811
type: ADRC
weighted_shares_outstanding: 171860238
